Literature DB >> 4184

Proceedings: The effects of AH 5158 on the overflow of transmitter and the uptake of (3H)-(--)-noradrenaline in the cat spleen.

A G Blakeley, R J Summers.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 4184      PMCID: PMC1666902     

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


× No keyword cloud information.
  3 in total

Review 1.  Presynaptic regulation of catecholamine release.

Authors:  S Z Langer
Journal:  Biochem Pharmacol       Date:  1974-07-01       Impact factor: 5.858

2.  Combined alpha- and beta-adrenoceptor blocking drug AH 5158: further studies on alpha-adrenoceptor blockade in anaesthetized animals.

Authors:  I Kennedy; G P Levy
Journal:  Br J Pharmacol       Date:  1975-04       Impact factor: 8.739

3.  Pharmacology of AH 5158; a drug which blocks both - and -adrenoceptors.

Authors:  J B Farmer; I Kennedy; G P Levy; R J Marshall
Journal:  Br J Pharmacol       Date:  1972-08       Impact factor: 8.739

  3 in total
  5 in total

1.  Pharmacological characterization of presynaptic alpha-adrenoceptors which regulate-cholinergic activity in the guinea-pig ileum [proceedings].

Authors:  G M Drew
Journal:  Br J Pharmacol       Date:  1977-03       Impact factor: 8.739

2.  The effects of AH 5158 on metabolism of 3H(-)noradrenaline released from the cat spleen by nerve stimulation [proceedings].

Authors:  R J Summers; J Tillman
Journal:  Br J Pharmacol       Date:  1976-10       Impact factor: 8.739

Review 3.  Labetalol: a review of its pharmacology and therapeutic use in hypertension.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1978-04       Impact factor: 9.546

4.  The effects of labetalol (AH 5158) on adrenergic transmission in the cat spleen.

Authors:  A G Blakeley; R J Summers
Journal:  Br J Pharmacol       Date:  1977-04       Impact factor: 8.739

Review 5.  Labetalol. A reappraisal of its pharmacology, pharmacokinetics and therapeutic use in hypertension and ischaemic heart disease.

Authors:  K L Goa; P Benfield; E M Sorkin
Journal:  Drugs       Date:  1989-05       Impact factor: 9.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.